|Title of Study||
Safety and Effectiveness of Vedolizumab IV in Real World Clinical Practice in Taiwan: A Registry-Based Study
To assess the safety of vedolizumab IV in patients with UC and CD in Taiwan.
To assess the effectiveness of vedolizumab IV in patients with UC and CD in Taiwan.
|Number of Sites||
At least 14 (all of the sites participating in “Prospective IBD patients Registration in Taiwan/台灣發炎性腸道疾病資料前瞻性登錄計畫”)
|Period of Study||
From：August 2017 to：May 2020
|Number of Patients||
At least 350人
|IRB Approval Date||
|Publication Plan / Date||